SJ Medical
SJ Medical
The Patent Foramen Ovale (PFO) closure device market is witnessing a transformative era in structural heart interventions. Clinically recognized as a significant factor in cryptogenic strokes and refractory migraines, the demand for minimally invasive PFO closure solutions has surged globally. Current industrial data suggests a steady CAGR of over 6% in this sector, driven by an aging population and advancements in echocardiographic diagnostic techniques.
In regions like North America and Europe, the shift toward ambulatory surgical centers (ASCs) has prioritized devices that offer rapid endothelialization and minimal thrombogenicity. As a leading hub for medical manufacturing, China has positioned itself as a critical supplier, bridging the gap between high-end clinical requirements and cost-effective industrial scalability.
Adult PFO Prevalence
Procedural Success Rate
Market CAGR
Countries Served
The next generation of PFO closure devices is moving toward bioresorbable scaffolds. These devices perform the temporary job of closing the shunt and then naturally dissolve, leaving no permanent foreign object in the heart, thus reducing long-term erosion risks.
Artificial Intelligence is being integrated into fluoroscopy and ICE (Intracardiac Echocardiography) to provide real-time 3D mapping, ensuring millimeter-precision placement of the occluder during the procedure.
Miniaturization of delivery catheters (reducing French sizes) is a key trend, allowing for femoral access with minimal trauma and faster patient discharge times, often within 24 hours.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Our comprehensive product portfolio covers key areas of vascular intervention, spanning from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
Through continuous innovation and strong R&D capabilities, SJ Medical has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
Equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
Certified Quality Management
International Regulatory Compliance
Our technical team consists of industry veterans with decades of experience in Nitinol wire braiding and biocompatible coating technologies, essential for high-performance PFO occluders.
As a China-based supplier, we offer a robust supply chain that guarantees consistent delivery schedules, even amidst global logistics fluctuations, ensuring hospitals never face stockouts.
We understand that clinical needs vary by region. Our R&D team works closely with global distributors to provide OEM/ODM services that adapt device sizing and delivery lengths to local patient demographics.
Global procurement teams from Europe, Asia, and the Middle East prioritize SJ Medical due to our rigorous adherence to international standards. By integrating the entire lifecycle from design to sterilization, we reduce overhead costs without compromising the medical-grade integrity required for intracardiac implants.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our footprint spans across Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt.
Italy, Spain, France
India, Indonesia
Turkey, Egypt
24/7 Tech Service
Choosing the right PFO closure device factory is a critical decision for healthcare providers and medical distributors. At Hangzhou SJ Medical, we combine high-tier engineering with a deep understanding of clinical pathology. Our commitment to E-E-A-T principles ensures that every device leaving our facility is backed by extensive research, manufacturing expertise, and a global reputation for reliability.
Whether you are looking for advanced balloon catheters, interventional access systems, or specialized structural heart occluders, our team is ready to provide the technical support and high-quality manufacturing your patients deserve. Explore the future of vascular intervention with China's premier medical device innovator.
